Phase III randomized study of fotemustine and dacarbazine versus dacarbazine with or without interferon-α in advanced malignant melanoma

被引：0
|
作者：
Antonio Daponte
Simona Signoriello
Luigi Maiorino
Bruno Massidda
Ester Simeone
Antonio Maria Grimaldi
Corrado Caracò
Giuseppe Palmieri
Antonio Cossu
Gerardo Botti
Antonella Petrillo
Secondo Lastoria
Ernesta Cavalcanti
Pasquale Aprea
Nicola Mozzillo
Ciro Gallo
Giuseppe Comella
Paolo Antonio Ascierto
机构：
[1] Istituto Nazionale Tumori Fondazione Pascale,Department of Melanoma
[2] Second University,Medical Statistics
[3] S.Gennaro Hospital Napoli,Medical Oncology
[4] University of Cagliari,Medical Oncology
[5] Institute of Biomolecular Chemistry,Unit of Cancer Genetics
[6] C.N.R.,Department of Pathology
[7] Azienda Ospedaliero Universitaria,Department of Pathology
[8] Istituto Nazionale Tumori Fondazione Pascale,Department of Radiology
[9] Istituto Nazionale Tumori Fondazione Pascale,Department of Nuclear Medicine
[10] Istituto Nazionale Tumori Fondazione Pascale,Laboratory Medicine Unit
[11] Istituto Nazionale Tumori Fondazione Pascale,Vascular Access Unit
[12] Istituto Nazionale Tumori Fondazione Pascale,undefined
[13] the Southern Italy Cooperative Oncology Group (SICOG),undefined
来源：
Journal of Translational Medicine | / 11卷
关键词：
Melanoma; Fotemustine; Dacarbazine; Interferon-α;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] FOTEMUSTINE, DACARBAZINE, VINDESINE COMBINATION CHEMOTHERAPY IN ADVANCED MALIGNANT-MELANOMA - A PHASE-II STUDY OF 43 PATIENTS
    RIXE, O
    BOREL, C
    PARAISO, D
    BENHAMMOUDA, A
    PETIT, T
    ANTOINE, E
    BIZZARI, JP
    AUCLERC, G
    SOUBRANE, C
    WELL, M
    GIROUX, B
    BANZET, P
    KHAYAT, D
    MELANOMA RESEARCH, 1995, 5 (06) : 419 - 424
  • [22] Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma (vol 18, pg 158, 2000)
    Middleton
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (11) : 2351 - 2352
  • [23] Phase III clinical trial of the combination of cisplatin, dacarbazine, and carmustine with or without tamoxifen in patients with advanced malignant melanoma
    Creagan, ET
    Suman, VJ
    Dalton, RJ
    Pitot, HC
    Long, HJ
    Veeder, MH
    Vukov, AM
    Rowland, KM
    Krook, JE
    Michalak, JC
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (06) : 1884 - 1890
  • [24] Dacarbazine-vindesine versus dacarbazine-vindesine-cisplatin in disseminated malignant melanoma.: A randomised phase III trial
    Jungnelius, U
    Ringborg, U
    Aamdal, S
    Mattsson, J
    Stierner, U
    Ingvar, C
    Malmström, P
    Andersson, R
    Karlsson, M
    Willman, K
    Wist, E
    Bjelkengren, G
    Westberg, R
    EUROPEAN JOURNAL OF CANCER, 1998, 34 (09) : 1368 - 1374
  • [25] Meta-Analysis of the Safety and Efficacy of Interferon Combined With Dacarbazine Versus Dacarbazine Alone in Cutaneous Malignant Melanoma
    Xin, Yong
    Huang, Qian
    Zhang, Pei
    Yang, Ming
    Hou, Xiao-Yang
    Tang, Jian-Qin
    Zhang, Long Zhen
    Jiang, Guan
    MEDICINE, 2016, 95 (16)
  • [26] Combined treatment with dacarbazine, cisplatin, fotemustine and tamoxifen in metastatic malignant melanoma
    Richard, MA
    Grob, JJ
    Zarrour, H
    Basseres, N
    Bizzari, JP
    Gerard, B
    Bonerandi, JJ
    MELANOMA RESEARCH, 1998, 8 (02) : 170 - 174
  • [27] Myelodysplastic syndromes after fotemustine and dacarbazine therapy for malignant melanoma.
    Perrot, JL
    Lanthier, K
    Benoit, F
    Graille, MC
    Guy, C
    Bertheas, MF
    Cambazard, F
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 1995, 122 (10): : 663 - 666
  • [28] COMBINATION CHEMOTHERAPY OF FOTEMUSTINE-DACARBAZINE AND INTERFERON-ALPHA FOR DISSEMINATED MALIGNANT-MELANOMA TREATMENT
    CELERIER, P
    DRENO, B
    BUREAU, B
    LITOUX, P
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 1993, 120 (6-7): : 437 - 440
  • [29] Dacarbazine and interferon alpha for stage IV malignant melanoma
    Tamm, I
    Grimme, H
    Bergen, E
    Simon, JC
    Schopf, E
    Mertelsmann, R
    Lindemann, A
    Brennscheidt, U
    ONCOLOGY, 1997, 54 (04) : 270 - 274
  • [30] PHASE-II STUDY OF INTERFERON ALPHA-2A AND DACARBAZINE IN ADVANCED MELANOMA
    BAJETTA, E
    NEGRETTI, E
    GIANNOTTI, B
    BROGELLI, L
    BRUNETTI, I
    SERTOLI, MR
    BERNENGO, MG
    SOFRA, MC
    MAIFREDI, G
    ZUMIANI, G
    COMELLA, G
    BUZZONI, R
    DILEO, A
    CRISCUOLO, D
    MASSIMINI, G
    CASCINELLI, N
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1990, 13 (05): : 405 - 409
12345